6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone CAS 179688-29-0 Erlotinib Hydrochloride Intermediate Purity>99.0% (HPLC)
Umvelisi ohamba phambili kunye nomthengisi we-Erlotinib Hydrochloride Intermediates
I-Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy)-3H-Quinazolin-4-enye CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Igama leMchiza | 6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-enye |
Izithethantonye | 6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone;I-6,7-Bis (2-Methoxyethoxy) -3,4-Dihydroquinazolin-4-enye;I-6,7-Bis (2-Methoxyethoxy) -4-Hydroxyquinazoline;I-6,7-Bis (2-Methoxyethoxy) -4-Quinazolinol;CP-380736 |
Ukungcola | Ukungacoceki kwe-Erlotinib A;Ukungcola kwe-Erlotinib Lactam |
Inombolo yeCAS | 179688-29-0 |
Inombolo yeCAT | RF2685 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C14H18N2O5 |
Ubunzima beMolekyuli | 294.31 |
Indawo yokunyibilika | 190.0 ukuba 194.0℃ |
Ukuxinana | 1.26±0.1 g/cm3 |
Inovakalelo | Ubuthathaka bomoya |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye oMhlophe |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Indawo yokunyibilika | 190.0 ukuba 194.0℃ |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | <0.20% |
Ukungcola okuNxulumeneyo yi-HPLC | |
Ukungacoceki komntu | <0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Iintsimbi ezinzima | <10ppm |
I-Infrared Spectrum | Iyahambelana neSakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Phakathi kwe-Erlotinib Hydrochloride (CAS: 183319-69-9) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
Ukuthenga njani?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eRashiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
I-6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-enye (i-CAS: 179688-29-0) iphakathi kwe-Erlotinib Hydrochloride (CAS: 183319-69-9).I-Erlotinib Hydrochlorate yi-molecule encinci ye-tyrosine kinase inhibitor esebenza ngokuguquguqukayo kwi-epidermal growth factor receptors, i-hydrochloride ye-erlotinib, ichiza elijoliswe kwi-molecular.I-US Food and Drug Administration (FDA) ivume i-erlotinib (i-Tarceva) idityaniswe ne-gemcitabine njengonyango lokuqala lomhlaza we-pancreatic kunye ne-metastatic.Isetyenziswa ikakhulu njengonyango lodidi lwesibini okanye lwesithathu kumhlaza wemiphunga okwinqanaba eliphezulu okanye i-metstatic non-small cell lung (NSCLC) kunye nonyango lomhlaza wepancreatic.Isetyenziswe njenge-tyrosine inhibitor yonyango lwe-NSCLC.Ikhompawundi encinci yemolekyuli i-Erlotinib Hydrochlorate yi-tyrosine kinase receptor inhibitor ethintela ukwanda kweeseli ze-tumor ngokuthintela i-phosphorylation, ibophelela kwi-intracellular catalytic domain ye-tyrosine kinase kukhuphiswano ne-ATP, ngaloo ndlela ivalela ukuhanjiswa komqondiso osezantsi kunye nokuthintela umsebenzi we-tumor cell ligand exhomekeke. HER-1/EGFR.